Why Compare These Compounds
BPC-157 and TB-500 are frequently grouped together in research literature and vendor catalogs as the “regeneration peptides” — short synthetic peptides studied in tissue research contexts. Despite the grouping, they are structurally and mechanistically distinct compounds. Understanding the differences helps researchers select appropriate compounds for specific protocols.
BPC-157
15 amino acids. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Notable structural feature: three consecutive prolines (positions 3–5) creating exceptional pH stability. Derived from a partial sequence of human gastric juice protein. Catalogued at PubChem CID 9941957. Most-published research areas: gastrointestinal lining models, soft tissue research, vascular formation studies. See our BPC-157 mechanism deep-dive.
TB-500
Synthetic 7-amino-acid fragment representing the active region of Thymosin Beta-4. Sequence: Leu-Lys-Lys-Thr-Glu-Thr-Gln. Significantly shorter than the parent Thymosin Beta-4 molecule (43 amino acids). Most-published research areas: actin sequestration studies, wound research models, vascular network formation research. The distinction between TB-500 and full Thymosin Beta-4 is critical for protocol design — see our TB-500 vs Thymosin Beta-4 article.
KPV
Tripeptide. Sequence: Lys-Pro-Val. The C-terminal three amino acids of α-MSH (alpha-melanocyte-stimulating hormone). Most-published research areas: inflammatory pathway research, intestinal barrier research models. Often paired with BPC-157 in research protocols due to overlapping research interest in gastrointestinal models.
Pentadeca Arginate
A newer 15-amino-acid analog that modifies the BPC-157 sequence by replacing terminal valine with arginine. Marketed as having improved stability and solubility profiles compared to standard BPC-157. Research literature is more limited given its more recent introduction.
Selection Considerations
For sequence-specific research, the compounds are not interchangeable — each has a distinct sequence designed for specific receptor interactions or stability profiles. For broader regeneration research contexts, the choice often depends on which compound has the most established research record in the specific tissue or model system. BPC-157 has the longest publication history; TB-500 has substantial actin-binding literature; KPV is best characterized in gastrointestinal contexts.
VialPepLab Catalog Coverage
Our catalog includes all four compounds with HPLC purity verification ≥99% and batch-specific COAs. Browse Healing & Regeneration for full specifications and current availability. See COA Library for batch records, or storage protocols for shelf-life guidance.